FY 27 DOD Appropriations FY 27 HHS Appropriations FY 27 VA Report Language Biodefense Funding
2026 · 2nd Quarter (Apr 1 - June 30)
PARATEK PHARMACEUTICALS
Filed by PARATEK PHARMACEUTICALS.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jun 26, 2026
- Income
- Not reported
- Expenses
- $20,000.00
- Registrant
- PARATEK PHARMACEUTICALS
- Client
- PARATEK PHARMACEUTICALS
- Filing UUID
- 0e987b97-5f77-4475-9d6e-2486462e7069
- Termination date
- Not reported
Expense method: A
Literal source text
Lobbying issues and bill citations
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.